ImportRefusal LogoImportRefusal

Laboratorios De Cosmetica Avanzada

⚠️ Moderate Risk

FEI: 3007006463 • Ciudad Autonoma Buenos Aires, Buenos Aires • ARGENTINA

FEI

FEI Number

3007006463

📍

Location

Ciudad Autonoma Buenos Aires, Buenos Aires

🇦🇷

Country

ARGENTINA
🏢

Address

Avenida Directorio 455, , Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina

Moderate Risk

FDA Import Risk Assessment

44.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

14
Total Refusals
10
Unique Violations
8/23/2010
Latest Refusal
2/9/2009
Earliest Refusal

Score Breakdown

Violation Severity
55.3×40%
Refusal Volume
43.6×30%
Recency
0.0×20%
Frequency
91.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

47111×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

19711×

COSM COLOR

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a color additive which is unsafe within the meaning of Section 721(a) which renders it adulterated under Section 601(e).

4748×

COSMETLBLG

It appears the label does not bear the common or usual name of the cosmetic.

4735×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4755×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

4832×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3442×

WARNINGS

It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

30001×

N-RX INACT

The article appears to be a nonprescription drug and fails to bear the established name of each inactive ingredient in alphabetical order on the outside container of the retail package.

Refusal History

DateProductViolationsDivision
8/23/2010
53LD01CLEANSING (COLD CREAMS, CLEANSING LOTIONS, LIQUIDS, PADS) (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
New Orleans District Office (NOL-DO)
3/12/2009
53CD04EYE LOTION (EYE MAKEUP PREPARATIONS)
471CSTIC LBLG
474COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53LC09SKIN FRESHENERS (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
474COSMETLBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53LC10WRINKLE SMOOTHING (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
473LABELING
474COSMETLBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
473LABELING
474COSMETLBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53GC03FOUNDATIONS (MAKEUP PREPARATIONS, NOT FOR EYES)
197COSM COLOR
471CSTIC LBLG
473LABELING
474COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53HD05NAIL POLISH AND ENAMEL (MANICURING PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
474COSMETLBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53GG01BLUSHERS (ALL TYPES) (MAKEUP PREPARATIONS, NOT FOR EYES)
197COSM COLOR
471CSTIC LBLG
473LABELING
474COSMETLBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
3/12/2009
53LC08PASTE MASKS (MUD PACKS) (SKIN CARE PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
New Orleans District Office (NOL-DO)
3/12/2009
53ED06SHAMPOOS (HAIR PREPARATIONS, NON-COLORING)
197COSM COLOR
471CSTIC LBLG
New Orleans District Office (NOL-DO)
2/9/2009
53CH03EYE SHADOW (EYE MAKEUP PREPARATIONS)
197COSM COLOR
471CSTIC LBLG
473LABELING
474COSMETLBLG
New Orleans District Office (NOL-DO)
2/9/2009
53GK05LIPSTICK (MAKEUP PREPARATIONS, NOT FOR EYES)
197COSM COLOR
New Orleans District Office (NOL-DO)
2/9/2009
62WAL99ASTRINGENT/ANTI-PERSPIRANT N.E.C.
118NOT LISTED
16DIRECTIONS
3000N-RX INACT
344WARNINGS
483DRUG NAME
New Orleans District Office (NOL-DO)
2/9/2009
62NCJ99ANTI-PSORIATIC N.E.C.
118NOT LISTED
16DIRECTIONS
344WARNINGS
483DRUG NAME
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Laboratorios De Cosmetica Avanzada's FDA import refusal history?

Laboratorios De Cosmetica Avanzada (FEI: 3007006463) has 14 FDA import refusal record(s) in our database, spanning from 2/9/2009 to 8/23/2010.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios De Cosmetica Avanzada's FEI number is 3007006463.

What types of violations has Laboratorios De Cosmetica Avanzada received?

Laboratorios De Cosmetica Avanzada has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios De Cosmetica Avanzada come from?

All FDA import refusal data for Laboratorios De Cosmetica Avanzada is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.